Literature DB >> 23952779

Aggregatibacter actinomycetemcomitans biofilm killing by a targeted ciprofloxacin prodrug.

Benjamin D Reeves1, Mark Young, Paul A Grieco, Peter Suci.   

Abstract

A pH-sensitive ciprofloxacin prodrug was synthesized and targeted against biofilms of the periodontal pathogen Aggregatibacter actinomycetemcomitans (Aa). The dose required to reduce the viability of a mature biofilm of Aa by ~80% was in the range of ng cm(-2) of colonized area (mean biofilm density 2.33 × 10(9) cells cm(-2)). A mathematical model was formulated that predicts the temporal change in the concentration of ciprofloxacin in the Aa biofilm as the drug is released and diffuses into the bulk medium. The predictions of the model were consistent with the extent of killing obtained. The results demonstrate the feasibility of the strategy to induce mortality, and together with the mathematical model, provide the basis for design of targeted antimicrobial prodrugs for the topical treatment of oral infections such as periodontitis. The targeted prodrug approach offers the possibility of optimizing the dose of available antimicrobials in order to kill a chosen pathogen while leaving the commensal microbiota relatively undisturbed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23952779      PMCID: PMC3818142          DOI: 10.1080/08927014.2013.823541

Source DB:  PubMed          Journal:  Biofouling        ISSN: 0892-7014            Impact factor:   3.209


  34 in total

1.  Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites.

Authors:  T B Conway; F M Beck; J D Walters
Journal:  J Periodontol       Date:  2000-09       Impact factor: 6.993

2.  Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide.

Authors:  Christopher W Kaplan; Jee Hyun Sim; Kevin R Shah; Aida Kolesnikova-Kaplan; Wenyuan Shi; Randal Eckert
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

3.  The distribution of oral mucosal pH values in healthy saliva secretors.

Authors:  D J Aframian; T Davidowitz; R Benoliel
Journal:  Oral Dis       Date:  2006-07       Impact factor: 3.511

4.  Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates.

Authors:  J A Hoogkamp-Korstanje; J Roelofs-Willemse
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

5.  Synthesis and biological properties of conjugates between fluoroquinolones and a N3''-functionalized pyochelin.

Authors:  Sabrina Noël; Véronique Gasser; Bénédicte Pesset; Françoise Hoegy; Didier Rognan; Isabelle J Schalk; Gaëtan L A Mislin
Journal:  Org Biomol Chem       Date:  2011-11-03       Impact factor: 3.876

6.  Synthesis and activities of pyoverdin-quinolone adducts: a prospective approach to a specific Therapy against Pseudomonas aeruginosa.

Authors:  C Hennard; Q C Truong; J F Desnottes; J M Paris; N J Moreau; M A Abdallah
Journal:  J Med Chem       Date:  2001-06-21       Impact factor: 7.446

7.  Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease.

Authors:  Y Li; C Messina; M Bendaoud; D H Fine; H Schreiner; V K Tsiagbe
Journal:  Mol Oral Microbiol       Date:  2010-08       Impact factor: 3.563

8.  A novel target-specific, salt-resistant antimicrobial peptide against the cariogenic pathogen Streptococcus mutans.

Authors:  Junni Mai; Xiao-Lin Tian; Jeffrey W Gallant; Nadine Merkley; Zakia Biswas; Raymond Syvitski; Susan E Douglas; Junqi Ling; Yung-Hua Li
Journal:  Antimicrob Agents Chemother       Date:  2011-08-15       Impact factor: 5.191

9.  Selective killing of Aggregatibacter actinomycetemcomitans by ciprofloxacin during development of a dual species biofilm with Streptococcus sanguinis.

Authors:  Peter Suci; Mark Young
Journal:  Arch Oral Biol       Date:  2011-04-19       Impact factor: 2.633

10.  A new small molecule specifically inhibits the cariogenic bacterium Streptococcus mutans in multispecies biofilms.

Authors:  Chang Liu; Roberta J Worthington; Christian Melander; Hui Wu
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

View more
  3 in total

1.  Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms.

Authors:  Parish P Sedghizadeh; Shuting Sun; Adam F Junka; Eric Richard; Keivan Sadrerafi; Susan Mahabady; Neema Bakhshalian; Natalia Tjokro; Marzenna Bartoszewicz; Monika Oleksy; Patrycja Szymczyk; Mark W Lundy; Jeffrey D Neighbors; R Graham G Russell; Charles E McKenna; Frank H Ebetino
Journal:  J Med Chem       Date:  2017-02-13       Impact factor: 7.446

Review 2.  Mini Review Therapeutic Strategies Targeting for Biofilm and Bone Infections.

Authors:  Shizhou Wu; Binjie Wu; Yunjie Liu; Shu Deng; Lei Lei; Hui Zhang
Journal:  Front Microbiol       Date:  2022-06-14       Impact factor: 6.064

3.  Prescription of Antibiotics for Periodontal Disease among Dentists in the Region of Tirana.

Authors:  Besian Abazi; Joana Mihani
Journal:  Open Access Maced J Med Sci       Date:  2018-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.